Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease

Ference, Brian A., Yoo, Wonsuk, Alesh, Issa, Mahajan, Nitin, Mirowska, Karolina K., Mewada, Abhishek, Kahn, Joel, Afonso, Luis +2 more·2012·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2012.09.017

Cited by (901)

Items 501–600 of 901

Association between remnant cholesterol and arterial stiffness: Evidence from NHANES 1999–2018
Tianjie Lai, Yiyin Liang, Fenglei Guan, Yunxian Chen, Konghe Hu · 2025 · Nutrition Metabolism and Cardiovascular Diseases
Brain‑heart axis: Neurostimulation techniques in ischemic heart disease (Review)
Yunnan Liu, Haimei Yang, Jian Xiong, Ying Wei, Yang Chen, Qianhua Zheng, Fanrong Liang · 2025 · International Journal of Molecular Medicine
Recomendaciones para la utilización clínica de los alimentos enriquecidos con fitoesteroles/fitoestanoles en el manejo de la hipercolesterolemia
Jordi Merino, L. Masana, Carlos Guijarro, Juan Francisco Ascaso, Manuel Lagares, Fernando Civeira · 2014 · Clínica e Investigación en Arteriosclerosis
The Legacy Effect in Treating Hypercholesterolemia
John B. Kostis, Mrinali Shetty, Yuvraj Singh Chowdhury, William J. Kostis · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
Xiangming Hu, Xing Yang, Xida Li, Demou Luo, Yingling Zhou, Haojian Dong · 2020 · Lipids in Health and Disease
Never too old to benefit from lipid-lowering treatment
Frederick Johan Raal, Farzahna Mohamed · 2020 · The Lancet
Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
Zhuoshan Huang, Xing Shui, Yesheng Ling, Linli Zhou, Wenqi Shi, Yanting Luo, Suhua Li, Jieming Zhu, Shujie Yu, Jinlai Liu · 2020 · Clinical Cardiology
Lipid Levels During Adult Lifetime in Men and Women With and Without a Subsequent Incident Myocardial Infarction: A Longitudinal Analysis of Data From the Tromsø Study 1974 to 2016
Grethe Albrektsen, Tom Wilsgaard, Ivar Heuch, Maja‐Lisa Løchen, Dag Steinar Thelle, Inger Njølstad, Sameline Grimsgaard, Kaare Harald Bønaa · 2023 · Journal of the American Heart Association
Neue AHA- und ACC-Leitlinie zur Risikoreduktion von Herz-Kreislauf-Erkrankungen durch Cholesterinsenkung
Gerald Klose, Frank Ulrich Beil, Hans Dieplinger, Arnold von Eckardstein, Bernhard Föger, Ioanna Gouni‐Berthold, Wolfgang Köenig, Gerhard Max Kostner, Ulf Landmesser, Ulrich Laufs et al. · 2014 · Der Internist
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study
Joshua Choi, Amir M Khan, Michael Jarmin, Naila Goldenberg, Charles J. Glueck, Ping Wang · 2017 · Lipids in Health and Disease
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
Yi‐Heng Li, Wei‐Kung Tseng, Wei‐Hsian Yin, Fang‐Ju Lin, Yen‐Wen Wu, Ching‐Lin Hsieh, Tsung‐Hsien Lin, Wayne Huey‐Herng Sheu, Hung‐I Yeh, Jaw‐Wen Chen et al. · 2020 · Scientific Reports
Efficacy and Safety of Naproxen for Acute Pain
Steven R Weisman · 2020 · The Journal of Family Practice
Strategies to alter the trajectory of atherosclerotic cardiovascular disease
Chris J. Packard · 2019 · Current Opinion in Lipidology
Advances in familial hypercholesterolemia
Martine Paquette, Alexis Wilfrid Baass · 2024 · Advances in clinical chemistry
Silencing hepatic PCSK9 via novel chimeric AAV8 mitigates the progression of atherosclerosis by inhibiting inflammation in ApoE−/− mice
Xiaocui Chen, Minghui Sun, Xiang Ma, Yitong Ma, Bang‐Dang Chen · 2024 · Molecular Therapy — Methods & Clinical Development
Effects of Accentuated Eccentric and Maximal Strength High-Resistance Training Programs with or Without a Curcumin-Based Formulation Supplement on Body Composition, Blood Pressure, and Metabolic Parameters in Older Adults
Álvaro Juesas, Ángel Saez-Berlanga, Carlos Babiloni-López, Ezequiel G. Martin, Luis Garrigues-Pelufo, Ana María Ferri-Caruana, Javier Gené‐Morales, Fernando Martin-Rivera, Iván Chulvi‐Medrano, Pablo Jiménez‐Martínez et al. · 2025 · Diseases
Pushing the limits of LDL cholesterol: Emerging paradigms in cardiovascular risk reduction
Dadmehr Yaghoubi, Tamer Sallam · 2025 · Trends in Cardiovascular Medicine
Mendelian randomization with proxy exposures: challenges and opportunities
Ida Rahu, Ralf Tambets, Eric B. Fauman, Kaur Alasoo · 2025 · Genetics
Secular trends in serum lipid profiles in young adults in Norway, 2001-19
Erik Arnesen, Kjetil Retterstøl · 2022 · Atherosclerosis Plus
Lipid-lowering therapy in patients with coronary artery disease undergoing percutaneous coronary interventions in Italy: an expert opinion paper of Interventional Cardiology Working Group of Italian Society of Cardiology
Paolo Calabrò, Carmen Spaccarotella, Arturo Cesaro, Giuseppe Andò, Raffaele Piccolo, Salvatore De Rosa, Marco Zimarino, Massimo Mancone, Felice Gragnano, Elisabetta Moscarella et al. · 2023 · Journal of Cardiovascular Medicine
Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study
Christoph F. Ebenbichler, Heinz Drexel, Ursula Hanusch, Hermann Toplak, Nafeesa N Dhalwani, Ian M. Bridges, Robert Hoelzl, Margit Hemetsberger, Kausik Kumar Ray · 2023 · Wiener klinische Wochenschrift
Phytosterol supplementation in capsules or tablets as adjunctive treatment for hypercholesterolemia: A systematic review of randomized controlled trials
Izabele Maria de Barros Lôbo, Carine de Oliveira Souza Bordallo, Joselita Moura Sacramento, Luana de Oliveira Leite, Poliana da Silva Santana · 2023 · Clinical Nutrition ESPEN
European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges
Angela Pirillo, Lale S Tokgözoğlu, Alberico Luigi Catapano · 2024 · Current Atherosclerosis Reports
Mendelian randomization in SLEEP: avoiding pitfalls with MR-SLEEP guidelines
Daniel S. Evans, Allan I Pack, David Gozal, Katie L. Stone · 2025 · SLEEP
A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk
Rutger Verbeek, Federico Oldoni, Ramya Preethi Surendran, Aeilko Having Zwinderman, Kay‐Tee Khaw, Erik S.G. Stroes, Nicholas J. Wareham, S. Matthijs Boekholdt, Geesje M. Dallinga‐Thie · 2019 · Journal of clinical lipidology
Practical guide for the use of PCSK9 inhibitors in Portugal
Ricardo Fontes‐Carvalho, Pedro Marques Silva, Elisabete Rodrigues, Francisco Pestana Araujo, Cristina Gavina, Jorge Ferreira, João Morais · 2019 · Revista Portuguesa de Cardiologia (English Edition)
Managing the Burden of Dementia-Related Delusions and Hallucinations
Small · 2020 · The Journal of Family Practice
In silico genome‐wide gene‐based association analysis reveals new genes predisposing to coronary artery disease
Irina V. Zorkoltseva, Alexandra S. Shadrina, Nadezhda M. Belonogova, Anatoly V. Kirichenko, Yakov A. Tsepilov, Tatiana I. Axenovich · 2021 · Clinical Genetics
Meat, vegetables and health — interpreting the evidence
Tammy Y. N. Tong, Keren Papier, Timothy J. Key · 2022 · Nature Medicine
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology
Giuseppe Patti, Ilaria Cavallari, Arturo Cesaro, Felice Gragnano, Letizia Riva, Fabio Fimiani, Claudio Cuccia, Claudio Fresco, Paolo Calabrò, Sergio Leonardi et al. · 2022 · Vascular Pharmacology
The association between body mass index and metabolite response to a liquid mixed meal challenge: a Mendelian randomization study
David A. Hughes, Ruifang Li‐Gao, Caroline J. Bull, Renée de Mutsert, Frits Richard Rosendaal, Dennis Owen Mook-Kanamori, Ko Willems van Dijk, Nicholas John Timpson · 2024 · American Journal of Clinical Nutrition
Integrated Preclinical Cardiovascular Prevention: A New Paradigm to Face Growing Challenges of Cardiovascular Disease
Massimo Volpe, Vittoria Mastromarino, Allegra Battistoni · 2015 · American Journal of Cardiovascular Drugs
Genetics—Current and Future Role in the Prevention and Management of Coronary Artery Disease
Robert Roberts · 2016 · Current Atherosclerosis Reports
Inhibiteurs de PCSK9 : quelle place dans la prise en charge actuelle des dyslipidémies ?
Pierre François Sabouret, Michel Farnier, Étienne Puymirat · 2019 · La Presse Médicale
Targeting LDL cholesterol: Early treatment is key to population health
Jane K. Stock · 2020 · Atherosclerosis
Percutaneous Inferior Vena Cava Valve Implantation May Improve Tricuspid Valve Regurgitation and Cardiac Output: Lessons Learned
Seyed Hossein Aalaei‐Andabili, Anthony A. Bavry, Calvin Choi, George J. Arnaoutakis, R. David Anderson, Thomas Mark Beaver · 2020 · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice
Massimo Puato, Alberto Zambon, Chiara Nardin, Elisabetta Faggin, Raffaele Pesavento, Alice Spinazzè, Paolo Pauletto, Marcello Rattazzi · 2021 · Cardiovascular Therapeutics
Cholesterol Control for Subclinical Coronary Atherosclerosis in Subjects Without Indication for Statin Therapy
Hyun Woo Park, Yong‐Giun Kim, Gyung‐Min Park, Sangwoo Park, Young–Rak Cho, Jon Suh, Yong Jik Lee, Dong Hyun Yang, Joon‐Won Kang, Hong‐Kyu Kim et al. · 2021 · The American Journal of Cardiology
Efficacy evaluation of PCSK9 monoclonal antibody (Evolocumab) in combination with Rosuvastatin and Ezetimibe on cholesterol levels in patients with coronary heart disease (CHD): A retrospective analysis from a single center in China
Yi Liu, Bing Han · 2021 · Transplant Immunology
Protective lipid-lowering variants in healthy older individuals without coronary heart disease
Paul A Lacaze, Moeen Riaz, Robert Sebra, Amanda J. Hooper, Jing Pang, Jane M. Tiller, Galina Polekhina, Andrew Maxwell Tonkin, Christopher Michael Reid, Sophia Zoungas et al. · 2021 · Open Heart
Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act
Giuseppe Musumeci, Gianmarco Annibali, Fabrizio Delnevo · 2023 · European Heart Journal Supplements
Improving Blood Pressure in Children Is Protective Over the Long Term
Justin P.V. Zachariah · 2013 · Circulation
A General Approach to Adjusting Genetic Studies for Assortative Mating
Marta Bilghese, Regina Manansala, Dhruva Jaishankar, Jonathan Jala, Daniel Jacob Benjamin, Miles Kimball, Paul Livermore Auer, Michael A. Livermore, Patrick Turley · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Effect of Phytosterols on Serum Levels of C-Reactive Protein: A Time- and Dose-Response Meta-analysis of Randomized Controlled Trial
Saeed Aslani, Mohammad Masoud Eslami, Ghasem Fakourizad, Ahmad Faisal Faiz, Keyhan Mohammadi, Omid Dehghan, Danyal Imani, Alireza Abbaspour, Tannaz Jamialahmadi, Bahman Razi et al. · 2024 · High Blood Pressure & Cardiovascular Prevention
Opportunities and challenges of PROTAC in the treatment of protein-driven diseases
Zhe Zhou, Peng Liu, Yang Li, Xuelian Liu, Jinyao Li · 2026 · Results in Chemistry
Prevalence of Silent Atherosclerosis across Adult Life
Henning Bundgaard, Inés García‐Lunar, Klaus Fuglsang Kofoed, Rasmus Bo Hasselbalch, Carlos Nicolás Pérez‐García, Joakim Bo Kunkel, Frederik Filip Stæger, Fátima Sánchez‐Cabo, José J. Fuster, Virginia Mass et al. · 2026 · New England Journal of Medicine
Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees
Jinsun Lee, Min Woo Kang, Juhwan Oh, Minsang Kim, Jung Hun Koh, Eunjeong Kang, Jeong Min Cho, Semin Cho, Seong Geun Kim, Soojin Lee et al. · 2025 · European Heart Journal - Quality of Care and Clinical Outcomes
The statin diabetes conundrum: short-term gain, long-term risk or inconvenient truth?
Robert J. DuBroff · 2015 · BMJ Evidence-Based Medicine
Single-nucleotide polymorphisms: a perspective of cardiovascular prevention
Guilherme Brasil Grezzana, José Luiz da Costa Vieira, Vera Lúcia Portal · 2015 · Revista da Associação Médica Brasileira
Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
Peter Paul Toth · 2021 · American Journal of Preventive Cardiology
Identification of candidate biomarkers and mechanisms in foam cell formation from heterogeneous cellular origins via integrated transcriptome analysis
Jing Xu, Yuejin Yang · 2023 · Annals of Translational Medicine
Still “on the Fence” About Universal Childhood Lipid Screening
Sarah D. de Ferranti, Andrew Edward Moran, Dhruv S. Kazi · 2023 · JAMA
Prognostic role of apolipoproteins on long-term major adverse cardiac events after percutaneous coronary intervention
Hiroshi Kawahara, Akihiro Endo, Kazuhiko Uchida, Kazuaki Tanabe · 2023 · Cardiovascular revascularization medicine
The association of appendicular lean mass and grip strength with low-density lipoprotein, very low-density lipoprotein, and high-density lipoprotein particle diameter: a Mendelian randomization study of the UK Biobank cohort
Richard Kirwan, Mohsen Mazidi, Tom Butler, Fátima Pérez de Heredia, Gregory Y.H. Lip, Ian Glynn Davies · 2024 · European Heart Journal Open
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT
P.M. Burger, Deepak L. Bhatt, Jannick A N Dorresteijn, Stefan Koudstaal, Arend Mosterd, Fabrice M A C Martens, Philippe Gabríel Steg, Frank L.J. Visseren, for the REDUCE-IT Investigators, Joanne Ladner et al. · 2024 · European Heart Journal - Cardiovascular Pharmacotherapy
PENELOPE 1-year follow-up: legacy effect of a short protocol-led LDL-C-lowering strategy in patients after myocardial infarction
Sander van der Brug, T J Van Trier, Aaram Omar Khader, Anho H Liem, Astrid Schut, Fabrice M A C Martens, Marco Alings, the PENELOPE investigators · 2025 · Netherlands Heart Journal
Serum cholesterol as a risk factor for coronary heart disease revisited
Je Rossouw · 2015 · South African Journal of Clinical Nutrition
Investigating the effects of statins on ischemic heart disease allowing for effects on body mass index: a Mendelian randomization study
Shun Li, C. Schooling · 2022 · Scientific Reports
A lipidologist perspective of global lipid guidelines and recommendations, part 1: Lipid treatment targets and risk assessment
Harold Edward Bays · 2015 · Journal of clinical lipidology
The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
Malwina Grobelna, Ewa Strauss, Zbigniew Krasiński · 2019 · Polish Journal of Cardio-Thoracic Surgery
Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy
Myung Han Hyun, Yu-Chang Lee, Byoung Geol Choi, Jin Oh Na, Cheol Ung Choi, Jin Won Kim, Eung Ju Kim, Seung‐Woon Rha, Chang Gyu Park, Eun Mi Lee et al. · 2019 · Cardiovascular Therapeutics
The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes
Myung Han Hyun, Jae Won Jang, Byoung Geol Choi, Jin Oh Na, Cheol Ung Choi, Jin Won Kim, Eung Ju Kim, Seung‐Woon Rha, Chang Gyu Park, Eun Mi Lee et al. · 2019 · Medicine
Effects of an eight-week exercise program on parameters of the lipid profile of female students
Irina Juhas, Branko Škof, Dejana Popović, Milan Matić, Nenad Janković · 2019 · Journal of Medical Biochemistry
Epidemiology and prevention of cardiovascular disease
Nathan D. Wong, Wenjun Fan · 2021
Reply
Brian A. Ference, Nitin Mahajan · 2013 · Journal of the American College of Cardiology
Predicting the effect of statins on cancer risk using genetic variants: a Mendelian randomization study in UK Biobank
Paul Carter, Mathew Kurian Vithayathil, Siddhartha Kar, Rahul Potluri, Amy M. Mason, Susanna C. Larsson, Stephen Burgess · 2020 · medRxiv
Evinacumab in patients aged 5–17 years with homozygous familial hypercholesterolemia
Robert S. Rosenson, Eliot A. Brinton, Daniel Gaudet, Frederick Johan Raal, Carissa Marrie Baker-Smith, Patrick M. Moriarty, Susanne Greber‐Platzer, Jean Bergeron, Brian W. McCrindle, Alpana Waldron et al. · 2025 · Atherosclerosis
Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice
Irene Karungi, Christophe A. T. Stevens, Julia Brandts, Kausik Kumar Ray · 2026 · American Journal of Preventive Cardiology
Global, regional, and national burden of ischemic heart disease attributable to metabolic risks: a systematic analysis of Global Burden of Disease 2021
Bo-Qing LIU, Chang Yang, H. Y. Wei, Zai-Xin YU · 2025 · 老年心脏病学杂志：英文版
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study
Éloi Gagnon, Dipender Gill, Jérôme Bourgault, Émilie Gobeil, Patricia L. Mitchell, Arnaud S. Girard, Audrey Paulin, Christian Couture, Yohan Bossé, Sébastien Thériault et al. · 2025 · Cardiovascular Research
The Pros and Cons of Mendelian Randomization Studies to Evaluate Emerging Cardiovascular Risk Factors
Jainy J. Savla, Ian J. Neeland · 2018 · Current Cardiovascular Risk Reports
Identification and treatment of those most at risk for premature atherosclerotic cardiovascular disease: We just cannot seem to get it right
Peter Paul Toth · 2020 · American Journal of Preventive Cardiology
The ever-growing burden of cardiovascular disease
Mehmet Birhan Yılmaz, Hakan Güneş · 2021 · Elsevier eBooks
Pediatric Lipid Disorders
Scott Leopold, Justin P.V. Zachariah · 2021 · Pediatric Annals
Association of adolescent lipoprotein subclass profile with carotid intima-media thickness and comparison to adults: Prospective population-based cohort studies
Raimund Pechlaner, Nele Friedrich, Anna Staudt, Nina Gande, Benoît Bernar, Katharina Stock, Sophia Zollner-Kiechl, Christoph Hochmayr, Andrea Griesmacher, Astrid Petersmann et al. · 2021 · Atherosclerosis
Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease
Justin P.V. Zachariah · 2023 · Current Atherosclerosis Reports
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
Nadeem Qureshi, Beth S. Woods, Rita Faria, Pedro Saramago, Edward Cox, Jo Leonardi‐Bee, Laura A. Condon, Stephen Franklin Weng, Ralph Kwame Akyea, Barbara Iyen et al. · 2023 · Health Technology Assessment
Prediction of LDL in hypertriglyceridemic subjects using an innovative ensemble machine learning technique
Ferhat Demirci, Murat Emeç, Özlem Gürsoy Doruk, Murat Örmen, Pınar Akan, Mehmet Hilal Özcanhan · 2023 · Turkish Journal of Biochemistry
Effect of Statin Therapy on Cardiovascular Outcome in Stroke Patients with Low Baseline Low‐Density Lipoprotein Cholesterol
Yong Soo Kim, Han‐Gil Jeong, Jun Young Chang, Jun Yup Kim, Beom Joon Kim, Hee‐Joon Bae, Moon‐Ku Han · 2024 · Annals of Neurology
Plant Sterol-Enriched Palm Oil Intervention to Improve Lipid Profile and Inflammation Status in Hyperlipidemic Individuals
Mira Dewi, Drajat Martianto, Nuri Andarwulan, Renata Kazimierczak, Dominika Średnicka-Tober · 2024 · Nutrients
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
Liwan Fu, Qin Liu, Hong Cheng, Xiaoyuan Zhao, Jingfan Xiong, Jie Mi · 2025 · Journal of the American Heart Association
Efficacy and Safety of Evolocumab in Improving Low-Density Lipoprotein Cholesterol (LDL-C) Levels in a Japanese Population ― Systematic Review and Meta-Analysis ―
Feng Sheng, Kazuma Miyawaki, Nobuhiro Osada, Satoru Tanaka, Zhaoyuan Liu, Toshiro Shinke · 2025 · Circulation Reports
Controllo lipidico in pazienti ad elevato rischio cardiovascolare: focus sull’inibizione di PCSK9
Pasquale Perrone Filardi, Stefania Paolillo, Bruno Trimarco · 2015 · Giornale italiano di cardiologia
Genetics in the prevention and management of coronary artery disease
Robert Roberts · 2018 · Current Opinion in Cardiology
Cardiovascular Risk Calculators and their Applicability to South Asians
Manish Bansal, Shraddha Ranjan, Ravi Ratan Kasliwal · 2020 · Current Diabetes Reviews
Adherence to lifestyle advice and its related cardiovascular disease risk among US adults with high cholesterol
Jie Guo, Qing Sun, Chaohui Wu, Jing Wu · 2022 · Clinical Nutrition ESPEN
Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
Shoa L. Clarke · 2023 · Current Opinion in Lipidology
Association between systolic blood pressure and low-density lipoprotein cholesterol with coronary heart disease according to age
Nelson Wang, Rima Mustafa, Verena Zuber, Anthony Rodgers, Abbas Dehghan · 2023 · PLoS ONE
A Pediatric Opportunity in Adolescents to Prevent Adult Heart Attacks
David S. Schade, Shirley J. Murphy, Vernat J. Exil, R. Philip Eaton · 2018 · World Journal of Cardiovascular Diseases
Clinical Strategies for Managing Dyslipidemias
Ulf Gunnar Bronas, Dereck L. Salisbury · 2013 · American Journal of Lifestyle Medicine
A lipidologist perspective of global lipid guidelines and recommendations, part 2: Lipid treatment goals
Harold Edward Bays · 2015 · Journal of clinical lipidology
Inferring causal relationships between phenotypes using summary statistics from genome-wide association studies
Xiang‐He Meng, Hui Shen, Xiang‐Ding Chen, Hong‐Mei Xiao, Hong‐Wen Deng · 2018 · Human Genetics
Particles and corrected particles of LDL and non-HDL are stronger predicters of coronary lesion in postmenopausal women
Chuang Li, Jingxun Chen, Siyue Wei, Mei Zhang, Yushun Chu, Fanpeng Meng, Jianyu Wang, Jie Ting Tang, Jian Luo, Yang Yu et al. · 2021 · BMC Cardiovascular Disorders
Reply
Brian A. Ference, Raju Penumetcha · 2015 · Journal of the American College of Cardiology
Prolonged and Pronounced Low-Density Lipoprotein Cholesterol Lowering: The Gift That Keeps Giving
Michael David Shapiro · 2022 · Circulation
Prevalence of carotid atherosclerosis in 3-92-year-old Finns. The 3-generational cardiovascular risk in young Finns study
Olli Tuomas Raitakari, Juhani S. Koskinen, Katja Pahkala, Suvi Rovio, Juha Mykkänen, Noora Kartiosuo, Sini Stenbacka, Irina Lisinen, Britt-Marie Loo, Terho J. Lehtimäki et al. · 2025 · Atherosclerosis
Non-HDL and LDL cholesterol, but not calculated remnant cholesterol, are associated with subclinical atherosclerosis
Malin Mickelsson, Per Liv, Kristina Stefansson, Kim Ekblom, Anders Själander, Emma Nyman, Christer Grönlund, Ulf Näslund, Johan Hultdin · 2025 · Journal of clinical lipidology
Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low‐Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study
H Zheng, Guanlin Chen, Zhenyu Huo, Yulong Lan, Yuxian Wang, Peng Fu, Weiqiang Wu, Haixiang Zheng, Kuangyi Wu, Zegui Huang et al. · 2026 · Journal of the American Heart Association
PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders: Heralding a New Therapeutic Era and Their Future Perspectives
Jitendra Gupta, Reena Gupta · 2022 · Current Molecular Pharmacology
Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention
Maria García-Gil, Lia Alves‐Cabratosa, Oriol Cunillera, Jordi Blanch, Ruth Martí‐Lluch, Anna Ponjoan, Francesc Ribas‐Aulinas, Èric Tornabell‐Noguera, Lluís Zacarías‐Pons, Gina Domínguez‐Armengol et al. · 2024 · European Journal of Clinical Investigation